Hideki Kunichika

Kashihara-shi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Three-dimensional image metric maps for characterizing local image changes associated with AI-based motion correction in coronary CT.

Three-dimensional image metric maps for characterizing local image changes associated with AI-based motion correction in coronary CT.

Journal: Radiological physics and technology

Published: April 21, 2026

Clinical Significance of Intratumoral Contrast Pooling on Contrast-Enhanced CT After Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

Clinical Significance of Intratumoral Contrast Pooling on Contrast-Enhanced CT After Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

Journal: Current oncology (Toronto, Ont.)

Published: November 06, 2025

Selective Conventional Transarterial Chemoembolization Using a Glass Membrane Emulsification Device in Hepatocellular Carcinoma: Multicenter Clinical Trial in Japan.

Selective Conventional Transarterial Chemoembolization Using a Glass Membrane Emulsification Device in Hepatocellular Carcinoma: Multicenter Clinical Trial in Japan.

Journal: Liver cancer

Published: October 22, 2025

Quantitative evaluation of tumor signal heterogeneity on gadoxetic acid-enhanced magnetic resonance imaging as a predictor of postoperative survival and antitumor immunity in hepatocellular carcinoma.

Quantitative evaluation of tumor signal heterogeneity on gadoxetic acid-enhanced magnetic resonance imaging as a predictor of postoperative survival and antitumor immunity in hepatocellular carcinoma.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 21, 2025

Hepatobiliary and Pancreatic Neoplasms: Essential Predictive Imaging Features for Personalized Therapy.

Hepatobiliary and Pancreatic Neoplasms: Essential Predictive Imaging Features for Personalized Therapy.

Journal: Radiographics : a review publication of the Radiological Society of North America, Inc

Published: February 06, 2025

Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI.

Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI.

Journal: Cancers

Published: May 10, 2024

Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma.

Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma.

Journal: Cancers

Published: April 01, 2024

Intra-arterial Therapy Using Micellar Nanoparticles Incorporating SN-38 in a Rat Pancreatic Tumor Model.

Intra-arterial Therapy Using Micellar Nanoparticles Incorporating SN-38 in a Rat Pancreatic Tumor Model.

Journal: Cardiovascular and interventional radiology

Published: February 06, 2024

Multimodality Imaging of Primary Hepatic Lymphoma: A Case Report and a Literature Review.

Multimodality Imaging of Primary Hepatic Lymphoma: A Case Report and a Literature Review.

Journal: Diagnostics (Basel, Switzerland)

Published: December 31, 2023

Predictive Factors of Complete Response to Transarterial Chemoembolization in Intermediate Stage Hepatocellular Carcinoma beyond Up-To-7 Criteria.

Predictive Factors of Complete Response to Transarterial Chemoembolization in Intermediate Stage Hepatocellular Carcinoma beyond Up-To-7 Criteria.

Journal: Cancers

Published: March 23, 2023

Vascular Normalization Caused by Short-Term Lenvatinib Could Enhance Transarterial Chemoembolization in Hepatocellular Carcinoma.

Vascular Normalization Caused by Short-Term Lenvatinib Could Enhance Transarterial Chemoembolization in Hepatocellular Carcinoma.

Journal: Current oncology (Toronto, Ont.)

Published: March 08, 2023

Quantitative Analysis of Signal Heterogeneity in the Hepatobiliary Phase of Pretreatment Gadoxetic Acid-Enhanced MRI as a Prognostic Imaging Biomarker in Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma.

Quantitative Analysis of Signal Heterogeneity in the Hepatobiliary Phase of Pretreatment Gadoxetic Acid-Enhanced MRI as a Prognostic Imaging Biomarker in Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma.

Journal: Cancers

Published: December 17, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026